Rbm24, a target of p53, is necessary for proper expression of p53 and heart development

被引:68
|
作者
Zhang, Min [1 ,2 ,3 ]
Zhang, Yanhong [1 ,2 ]
Xu, Enshun [1 ,2 ]
Mohibi, Shakur [1 ,2 ]
de Anda, Danielle Michelle [1 ,2 ]
Jiang, Yuqian [1 ,2 ]
Zhang, Jin [1 ,2 ]
Chen, Xinbin [1 ,2 ]
机构
[1] Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Davis, CA 95616 USA
[2] Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA
[3] Huazhong Agr Univ, Coll Life Sci & Technol, Wuhan, Hubei, Peoples R China
来源
CELL DEATH AND DIFFERENTIATION | 2018年 / 25卷 / 06期
关键词
RNA-BINDING PROTEIN; IMPROVES CARDIAC-FUNCTION; REGULATES P63 EXPRESSION; ENDOCARDIAL CUSHION; CARDIOMYOCYTE APOPTOSIS; PUMA; TRANSLATION; DELETION; FAILURE; FAMILY;
D O I
10.1038/s41418-017-0029-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of p53-dependent apoptosis is critical for tumor suppression but aberrant activation of p53 also leads to developmental defects and heart failure. Here, we found that Rbm24 RNA-binding protein, a target of p53, regulates p53 mRNA translation. Mechanistically, we found that through binding to p53 mRNA and interaction with translation initiation factor eIF4E, Rbm24 prevents eIF4E from binding to p53 mRNA and inhibits the assembly of translation initiation complex. Importantly, we showed that mice deficient in Rbm24 die in utero due to the endocardial cushion defect in the heart at least in part due to aberrant activation of p53-dependent apoptosis. We also showed that the heart developmental defect in Rbm24-null mice can be partially rescued by p53 deficiency through decreased apoptosis in the heart. Together, we postulate that the p53-Rbm24 loop is critical for the heart development and may be explored for mitigating congenital heart diseases and heart failure.
引用
收藏
页码:1118 / 1130
页数:13
相关论文
共 50 条
  • [21] Expression of p53 in endometrial polyps with special reference to the p53 signature
    Sho, Tomoko
    Hachisuga, Toru
    Kawagoe, Toshinori
    Urabe, Rie
    Kurita, Tomoko
    Kagami, Seiji
    Shimajiri, Shohei
    Fujino, Yoshihisa
    HISTOLOGY AND HISTOPATHOLOGY, 2016, 31 (07) : 751 - 758
  • [22] The glial response to CNSHIV infection includes p53 activation and increased expression of p53 target genes
    Jayadev, Suman
    Yun, Bomy
    Nguyen, Huy
    Yokoo, Hideaki
    Morrison, Richard S.
    Garden, Gwenn A.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2007, 2 (04) : 359 - 370
  • [23] Target p53 functionally null ovarian cancers for p53 gene replacement: Not all p53 mutations are created equal!
    Buller, RE
    Shahin, MS
    Hughes, JH
    Sorosky, JI
    Anderson, B
    Sood, AK
    CANCER GENE THERAPY, 1999, 6 (06) : S4 - S4
  • [24] Functional characterization of p53β and p53γ, two isoforms of the tumor suppressor p53
    Graupner, Vilma
    Schulze-Osthoff, Klaus
    Essmann, Frank
    Jaenicke, Reiner U.
    CELL CYCLE, 2009, 8 (08) : 1238 - 1248
  • [25] P53 expression in myelodysplasia
    Chalmers, J.
    Pawade, J.
    Johansson, U.
    Clench, T.
    VIRCHOWS ARCHIV, 2014, 465 : S279 - S279
  • [26] EXPRESSION OF P53 IN OLIGODENDROGLIOMAS
    KROS, JM
    GODSCHALK, JJCJ
    KRISHNADATH, KK
    VANEDEN, CG
    JOURNAL OF PATHOLOGY, 1993, 171 (04): : 285 - 290
  • [27] p53 β-hydroxybutyrylation attenuates p53 activity
    Kun Liu
    Fangzhou Li
    Qianqian Sun
    Ning Lin
    Haichao Han
    Kaiqiang You
    Feng Tian
    Zebin Mao
    Tingting Li
    Tanjun Tong
    Meiyu Geng
    Yingming Zhao
    Wei Gu
    Wenhui Zhao
    Cell Death & Disease, 10
  • [28] p53 β-hydroxybutyrylation attenuates p53 activity
    Liu, Kun
    Li, Fangzhou
    Sun, Qianqian
    Lin, Ning
    Han, Haichao
    You, Kaiqiang
    Tian, Feng
    Mao, Zebin
    Li, Tingting
    Tong, Tanjun
    Geng, Meiyu
    Zhao, Yingming
    Gu, Wei
    Zhao, Wenhui
    CELL DEATH & DISEASE, 2019, 10 (3)
  • [29] p53 isoforms change p53 paradigm
    Bourdon, J. C.
    MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (04):
  • [30] Arsenite inhibits p53 phosphorylation, DNA binding activity and p53 target gene p21expression
    Tang, Faqing
    Liu, Guangming
    He, Zhiwei
    Ma, Wei-Ya
    Bode, Ann M.
    Dong, Zigang
    CANCER RESEARCH, 2006, 66 (08)